Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bellerophon Therapeutics Inc. BLPH

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. The firm develops innovative products combining novel drugs and devices to treat cardiopulmonary diseases. It develops products under its INOpulse platform, which is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. The company products are aimed at the treatment of different kinds of pulmonary hypertension.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Nitric Oxide Company passes Phase 3

Canadian company SaNOtize’s COVID-19 treatment wins approval in India A treatment for COVID-19 that was developed in British Columbia has been approved for sale in India, where it could be shipped to...read more

RE:RE:Volume is up

Yes keep your eye on this one, they're using Nitric Oxide in their process. N.O. is going to be Hot one of these days, front page news IMO  rate and reply

RE:Volume is up

A lot of Bio stocks are seeing increased volatility. New viruses every month and cannabis legalization in the US starting with safe banking is possibly why. That's a very generalized perspective,...read more

Volume is up

34 million traded so far today, that's 1000 times normal for this stock and today's not even half over   rate and reply

News

Bellerophon Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Sarcoidosis  rate and reply

Interesting

Interesting product  rate and reply